Serimmune Inc. is an immune intelligence company that provides a holistic view of immunity to identify environmental factors in disease and health. The unique information they provide fuels development of new diagnostics, vaccines, and therapeutics.
Founded in 2014, and backed by investors including Illumina Ventures, LabCorp, and Merck, Serimmune is developing new approaches for preventing, diagnosing, and treating a range of diseases.
The company's slogan "Mapping Human Immunity - Generating Insights to Improve Health" accurately reflects its mission and vision, addressing a crucial need in the Biotechnology, Health Care, and Information Technology industries. Headquartered in the United States, their most recent milestone was a $12.05M Venture Round investment at 11 September 2020.